Published in Biotech Business Week, July 6th, 2009
"Long-term 5 year cancer-specific Survival rates have recently been reported for laparoscopic partial nephrectomy. These results are comparable to open partial nephrectomy series. As the field of robotic assisted surgery continues to expand beyond the treatment of prostate cancer, these techniques are being investigated in the treatment of small renal masses. Currently, minimally...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.